USANA Health Sciences, Inc. (USNA) Social Stream
USANA HEALTH SCIENCES INC (USNA) Price Targets From Analysts
Use the tables below to see what analysts covering USANA HEALTH SCIENCES INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-27 | 1 | $90 | $90 | $90 | $50.5 | 78.22% |
| 2022-02-10 | 2 | $78 | $78 | $78 | $50.5 | 54.46% |
| 2022-04-14 | 2 | $86 | $78 | $82 | $50.5 | 62.38% |
| 2022-04-27 | 2 | $78 | $76 | $77 | $50.5 | 52.48% |
| 2022-07-12 | 2 | $58 | $53 | $55.5 | $50.5 | 9.9% |
| 2022-07-28 | 2 | $57 | $53 | $55 | $50.5 | 8.91% |
| 2022-10-27 | 1 | $49 | $49 | $49 | $50.5 | -2.97% |
| 2023-02-13 | 1 | $52.5 | $52.5 | $52.5 | $50.5 | 3.96% |
| 2023-04-26 | 1 | $56 | $56 | $56 | $50.5 | 10.89% |
| 2023-07-17 | 2 | $72 | $56 | $64 | $50.5 | 26.73% |
| 2023-07-26 | 2 | $74 | $56 | $65 | $50.5 | 28.71% |
| 2023-10-10 | 2 | $74 | $62 | $68 | $50.5 | 34.65% |
| 2023-10-26 | 2 | $74 | $53 | $63.5 | $50.5 | 25.74% |
| 2023-11-20 | 2 | $68 | $53 | $60.5 | $50.5 | 19.8% |
The Trend in the Analyst Price Target
Over the past 16 months, USNA's average price target has gone up $3.5.
Over the past 40 weeks, USNA's average upside potential has been 6.93%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-13 | 1 | 52.5 | 52.5 | 52.5 | 61.12 | -14.1% |
| 2023-06-23 | 2 | 72.0 | 56.0 | 64.0 | 61.03 | 4.87% |
| 2023-07-17 | 2 | 72.0 | 56.0 | 64.0 | 61.33 | 4.35% |
| 2023-10-10 | 2 | 74.0 | 62.0 | 68.0 | 58.46 | 16.32% |
| 2023-11-20 | 2 | 68.0 | 53.0 | 60.5 | 46.24 | 30.84% |
USNA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 1 | 0 | 1 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
Over the past 40 months, USNA's average broker recommendation rating improved by 1.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- USNA has a higher number of analysts covering the stock than 28.3% of all US stocks.
- USANA HEALTH SCIENCES INC's variance in analysts' estimates is lower than 15.52% of Pharmaceutical Products stocks.
- In terms of how USANA HEALTH SCIENCES INC fares relative to Pharmaceutical Products stocks, note that its average analyst price target is greater than 1223.28% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, USANA HEALTH SCIENCES INC's upside potential (average analyst target price relative to current price) is higher than 437.72% of them.
In the Pharmaceutical Products industry, LNTH, RIOT, and MYGN are the three stocks most similar to USANA HEALTH SCIENCES INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for USNA? Use POWR Ratings for clearer insight into price direction.